Allergic Rhinitis Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Allergic Rhinitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Allergic Rhinitis Market Size and Its Estimated Growth Rate?
In recent years, there has been a consistent increase in the market size of allergic rhinitis. It is projected to rise from $15.22 billion in 2024 to $15.74 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.4%. The growth during the previous period is as a result of reasons such as exposure to allergens, shifting environmental conditions, heightened public cognizance, escalating pollution, enhanced research and developments addressing allergic rhinitis, and increasing disposable incomes.

In the upcoming years, there will be a stable growth in the size of the allergic rhinitis market, which is projected to reach $18.49 billion in 2029, growing at a compound annual growth rate (CAGR) of 4.1%. The anticipated expansion during this period can be linked to a demand for preventive treatments, increase in elderly populations, urbanization, and health care expenditure. Dominant trends for this forecast period consist of biologics and monoclonal antibodies, digital health solutions, strategies to avoid allergens, pediatric allergic rhinitis, and technology used in allergen detection.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12926

How Are Emerging Segments Shaping the Allergic Rhinitis Market Landscape?
The allergic rhinitis market covered in this report is segmented -

1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis
2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments
3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count
4) By Route Of Administration: Oral, Nasal, Other Route Of Administration
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores

Subsegments:
1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy
2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy
3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp

Which Growth Factors Are Influencing Allergic Rhinitis Market Expansion?
Air pollution and climate change, both with high levels, are anticipated to advance the growth of the allergic rhinitis market. The definition of air pollution pertains to the existence of detrimental substances in our planet's atmosphere that can negatively impact human health, environment, and the air we inhale. Climate change, on the other hand, pertains to the long-lasting transformations in Earth's climate trends, including change in temperature, rainfall, and other climatic elements. Rampant air pollution has been acknowledged as a crucial environmental factor that elevates the prevalence and severity of allergic rhinitis, illustrating the intricate connection between air quality and respiratory health. For instance, in August 2024, as reported by the United States Environmental Protection Agency, a US government body, there were roughly 66 million tons of pollutants discharged into the atmosphere all over the United States in the year 2023. For this reason, high levels of air pollution and climate change positively affect the growth of the allergic rhinitis market. Moving to the next driver, the rise in the use of corticosteroid treatment for allergic rhinitis is also projected to push the growth of the allergic rhinitis market. Corticosteroid treatment, otherwise known as steroid treatment, makes use of medications typically known as corticosteroids or simply steroids. These steroids are widely used in the management of allergic rhinitis as they alleviate inflammation within the nasal passages and mitigate the symptoms linked to this condition. For instance, in September 2023, in accordance with the American Society for Clinical Pharmacology and Therapeutics, a professional organization based in the US, there was an average corticosteroid utilization rate of 6.8% in the US, 17.5% in Taiwan, and 2.2% in Denmark, with an annual surge ranging from 0.1% to 0.17%. Most prescribed steroids were for brief periods (1-29 days) and were intended for healthy adults suffering from self-limiting conditions such as respiratory infections. Thus, the rise in corticosteroid treatment for allergic rhinitis propels the growth of the allergic rhinitis market.

Who Are the Dominant Players Across Different Allergic Rhinitis Market Segments?
Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.

What Are the Latest Developing Trends in the Allergic Rhinitis Market?
Leading companies in the allergic rhinitis market are forging ahead with the creation of novel medications to cement their standing. For instance, Hikma Pharmaceuticals PLC, a pharmaceutical firm in the UK, and Glenmark Specialty S.A, a Switzerland-based pharmaceutical enterprise, received approval for their product Ryaltris from the United States Food and Drug Administration (FDA), a federal agency in the US, in August 2022. Ryaltris is the inaugural fixed-dose combination drug that offers treatment for nasal and ocular signs of seasonal allergic rhinitis, conveniently delivered via a nasal spray for adults and children aged 12 and above. Nasal symptom relief begins to work within 15 minutes of administering the initial dose.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Which Geographic Regions Are Expected to Dominate the Allergic Rhinitis Market in the Coming Years?
North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Allergic Rhinitis Market?
2. What is the CAGR expected in the Allergic Rhinitis Market?
3. What Are the Key Innovations Transforming the Allergic Rhinitis Industry?
4. Which Region Is Leading the Allergic Rhinitis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.